Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
The final regulatory wording for retatrutide including any warnings or precautions relating to thyroid disease has not yet been determined, as the medicine has not been approved
Participants receiving the highest dose (12mg weekly) achieved a least-squares mean weight change of -24.2% at 48 weeks
It is unknown whether TRULICITY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of dulaglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions (5.1), and Nonclinical Toxicology (13.1)]
An amount of 25 L of each starting sample was collected after vortexing for 5 min
Food and Drug Administration Location Finder Here's your guide to finding any of the facilities in the Aultman family of health services, including maps and contacts
